期刊文献+

口腔黏膜白斑及鳞癌中p57^(KIP2)蛋白的表达及其意义

Expressions of p57^(KIP2) protein in oral leukoplakia and oral squamous cell carcinoma and its clinical significance
下载PDF
导出
摘要 目的通过检测p57KIP2蛋白在不同程度异型增生的口腔黏膜白斑及鳞癌中的表达,以探讨其在口腔黏膜白斑及鳞癌中的意义。方法以10例正常口腔黏膜作对照,采用免疫组织化学S-P法回顾性研究79例口腔白斑和67例口腔鳞癌中p57的表达情况。统计分析不同程度异型增生中及鳞癌中p57KIP2蛋白表达的差异。结果 79例口腔黏膜白斑组织中p57KIP2表达率为77.2%(61/79),显著低于正常口腔黏膜(10/10)(χ2=22.510,P<0.01)。在白斑组织中,随着异型增生程度增高,p57KIP2蛋白的表达率有下降的趋势(85.0%,70.0%,68.4%),但差异无统计学意义。p57在轻度异性型增生白斑中的表达显著低于正常黏膜组织(P<0.05),而在鳞癌中的表达又显著低于中重度异型增生白斑(P<0.05)。结论口腔黏膜白斑组织中的p57KIP2蛋白表达显著低于正常口腔黏膜组织,提示从正常口腔黏膜到作为癌前病变的口腔黏膜白斑的发展过程中存在p57KIP2蛋白的表达丧失。p57是预测口腔鳞癌进展和预后的一个生物指标。 Objective To investigate the expressions of p57KIP2 protein in oral leukoplakia and oral squamous cell carcinoma and its clinical significance.Methods Tissue specimens were collected from 79 cases of leukoplakia,67 cases of oral squamous cell carcinoma(SCC) and 10 cases of normal oral mucosa.The expression of p57 proteins was detected with immunohistochemical S-P method.Results The expression rate of p57KIP2 protein in leukoplakia was 77.2%(61/79),lower than that in normal oral mucosa(100.0%,10/10)(χ2=22.510,P0.01).p57 expression was decreased progressively from normal mucosa to leukoplakia with mild dysplasia,from mild to moderate or severe dysplasia in leukoplakia,and from leuoplakia to SCC.Conclusion The down-regulated expression of p57KIP2 protein may be associated with the development of oral leukoplakia,which might be used as a biomarker for the progress and prognosis of oral SCC.
出处 《实用肿瘤杂志》 CAS 北大核心 2010年第6期667-670,共4页 Journal of Practical Oncology
关键词 口腔肿瘤/病理学 白斑 口腔/病理学 鳞状细胞 基因表达 周期素依赖激酶抑制剂p57 回顾性研究 预后 mouth neoplasms/pathology leukoplakia oral/pathology carcinoma squamous cell gene expression cyclin-dependent kinase inhibitor p57 retrospective studies prognosis
  • 相关文献

参考文献9

  • 1Sherr CJ. Cancer cell cycles [ J]. Science, 1996,274 ( 5293 ) : 1672 - 1677.
  • 2Grana X, Reddy EP. Cell cycle control in mammalian cells : role of cyclins, cyclin dependent kinase ( CDKs ) , growth suppressor genes and cyclin dependent kinase inhibitors(CDKIs) [ J]. Oncogene, 1995,11 ( 2 ) : 211 - 219.
  • 3Yinghua L, Hirokazu N, Toshigito O, et al. Aberrant DNA methylation of p57KIP2 gene in the promoter region in lymphoid malignancies of B-cell phenotype [ J ]. Blood,2002,100 (7) :2572 - 2577.
  • 4Yang X, Karuturi RK, Sun F, et al. CDKN1C ( p57 ) is a direct target of EZH2 and suppressed by multiple epigenetlc mechanisms in breast cancer cells [ J ]. PLoS One,2009,4(4) :5011.
  • 5Ciaparrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27^KIP1 in multistage colorectal carcinogenesis [JJ. Cancer Res, 1998,58 ( 1 ) : 114 - 122.
  • 6Lee MH, Reynisdottir I, Massague J. Cloning of p57^KIP2 , a eyelin-dependent kinase inhibitor with unique domain structure and tissue distribution [ J]. Gene Dev, 1995,9 (6) :639-649.
  • 7Pateras IS, Apostolopoulou K, Koutsami M, et al. Downregulation of the KIP family members p27 ( KIP1 ) and p57 (KIP2) by SKP2 and the role of methylation in p57 (KIP2) by SKP2 and the role of methylation in p57 ( KIP2 ) inactivation in nonsmall cell lung cancer [ J ]. Int J Cancer,2006,119 ( 11 ) :2546 - 2556.
  • 8Shin J, Kim H, Park J, et al. Mechanism for inactivation of KIP family cyclin-dependent kinase inhibitor gene in gastric cancer cells [ J ]. Cancer Res, 2000,60 (2) : 262 - 265.
  • 9Vlachas P, Nyman U, Hajji N, et al. The cell cycle inhibitor p57 (Kip2) promotes cell death via the mitochondrial apoptotic pathway [ J ]. Cell Death Differ, 2007,14 ( 8 ) : 1497 - 1507.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部